The OECD Environmental, Health and Safety (EHS) Programme has been helping member countries to make better use of increased knowledge of how chemicals induce adverse effects in humans and wildlife, through the so-called Adverse Outcome Pathways.

What's new

OECD releases seven publications on Adverse Outcome Pathways (AOPs)

Adverse Outcome Pathway on Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF, Amani Farhat l 30 July 2019 Adverse Outcome Pathway on Aryl hydrocarbon receptor activation leading to uroporphyria, Amani Farhat, et al l 20 July 2019 Adverse Outcome Pathway on inhibition of Na+/l- symporter (NIS) leads to learning and memory impairment, Alexandra Rolaki, et al l 30 July 2019 Adverse Outcome Pathway on inhibition of Thyroperoxidase and subsequent adverse neurodevelopmental outcomes in mammals, Kevin M. Crofton, et al l 30 July 2019 Adverse Outcome Pathway on aryl hydrocarbon receptor activation leading to early life stage mortality via increased COX-2, Jon Doering, et al l 30 July 2019 Adverse Outcome Pathway binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain, Ping Gong and Edward J. Perkins l 30 July 2019 Adverse Outcome Pathway on antagonist binding to PPARa leading to body-weight loss, Kurt A. Gust, et al l 30 July 2019   All publications in the Series on Adverse Outcome Pathways can be found here.

What is an Adverse Outcome Pathway?

The OECD launched a new programme on the development of Adverse Outcome Pathways (AOP) in 2012. An AOP is an analytical construct that describes a sequential chain of causally linked events at different levels of biological organisation that lead to an adverse health or ecotoxicological effect (see figure below). AOPs are the central element of a toxicological knowledge framework being built to support chemical risk assessment based on mechanistic reasoning.

 

Schematic representation of the AOP illustrated with reference to a number of pathways

 

Watch our video: OECD work on Adverse Outcome Pathway

 

The AOP Development Programme

The AOP development programme is overseen by the extended Advisory Group on Molecular Screening and Toxicogenomics (EAGMST). EAGMST members are nominated by their National Coordinators; they play an active role in the development of AOPs, as well as in the internal review process.

• Find the OECD's Series on Adverse Outcome Pathways.
• The development of an AOP can be proposed by research teams in OECD countries. Form to complete and submit an AOP Project proposal.
• The users' handbook for AOP development should be followed as it provides practical guidance for developing an AOP in the AOP Wiki platform.
• The AOP workplan is updated in June and December every year.
• AOP development and review process at OECD.

Representation of the AOP Development Process

‌ 

 

AOP Knowledge Base and Tools

The OECD's AOP Knowledge Base tools, constantly developed and refined, are a web-based platform which aims to bring together all knowledge on how chemicals can induce adverse effects, therefore providing a focal point for AOP development and dissemination.

The e AOP Portal is the main entry point of the AOP Knowledge Base. A search engine, the Portal enables search by key words in AOP titles and key events in the AOP Wiki and Effectopedia platforms. It houses the status of all AOPs in the OECD Work Plan and the official copy of OECD endorsed AOPs.

The AOP Wiki provides a system that organises, via crowd-sourcing, the available knowledge and published research into a verbal description of individual pathways, using a user friendly Wiki interface. Information on AOP is collected in a qualitative, narrative way.

Effectopedia is an open-knowledge and structured platform able to display information on Adverse Outcome Pathways. It uses visually expressed modular structures to capture semantically annotated knowledge and algorithms together with all the supporting evidence.

Find out more

Test Guidelines Programme The OECD Test Guidelines Programme for the identification of new biomaker endpoints and in vitro test methods that are candidates to become part of OECD Test Guidelines.

Hazard Assessment Activities The OECD Hazard Assessment activities for the development of Integrated Approaches to Testing and Assessment (IATA, using AOPs as a framework. The OECD QSAR project for the identification of new methods/profilers for grouping chemicals.

ENGAGE WITH US

• Stay tuned on Twitter: @OECD_ENV
• For more information, please contact: ehs.contact@oecd.org
• To receive our latest Chemical Safety and Biosafety news, publications and events, sign up to MyOECD.